Firsthand Technology Value Fund Discloses Top Portfolio Holdings
Mar 12, 2018 20:05 pm UTC| Business
SAN JOSE, Calif., March 12, 2018 -- Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its...
The New Ireland Fund to Ring NYSE Opening Bell
Mar 12, 2018 20:05 pm UTC| Business
BOSTON, March 12, 2018 -- Margaret Duffy, Chair of the Board of Directors (the “Board”) of The New Ireland Fund (NYSE:IRL) (the “Fund”), a closed-end investment company, will ring The Opening Bell® tomorrow morning at...
Clarus Reports Strong Fourth Quarter and Full Year 2017 Results
Mar 12, 2018 20:05 pm UTC| Business
- Q4 Sales up 27% to $52.7 Million With Gross Margin up 350 Basis Points to 32.6% (Adjusted Gross Margin up 670 Basis Points to 35.8%) – - Full Year 2018 Sales to Grow 17%-20% to Approximately $200-$205 Million - SALT...
Mar 12, 2018 20:05 pm UTC| Business
Southfield, Michigan, March 12, 2018 -- We are pleased to announce that Great Place to Work honored Kathy Kantzer, Senior Vice President – Front End Loan Servicing, at its inaugural Great Place to Work® For All™...
BioXcel Therapeutics Announces Closing of Initial Public Offering
Mar 12, 2018 20:01 pm UTC| Business
BRANFORD, Conn., March 12, 2018 -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines...
Mistras Group Announces Fourth Quarter 2017 Results
Mar 12, 2018 20:01 pm UTC| Business
Highlights of the Fourth Quarter 2017* Consolidated Q4 revenues increased 10%; Services segment revenues increased 17%Q4 pretax income of $5.0 million increased 140%Q4 net income was $0.9 million; non-GAAP net income...
Vyome Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference
Mar 12, 2018 20:01 pm UTC| Business
NEW DELHI, India, March 12, 2018 -- Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announces that N....